Guidelines

• NCCN Guidelines Version 4.2023

Evidence Blocks

• NCCN Guidelines with Evidence Blocks Version 4.2023

Frameworks

• Basic Resources (English) Version 2.2021

• Core Resources (English) Version 2.2021

• Enhanced Resources (English) Version 2.2021

Guidelines for Patients

• Prostate Cancer: Early Stage-English Version 2023

• Prostate Cancer: Advanced Stage-English Version 2023

• Prostate Cancer: Advanced Stage-Korean Version 2020

• Prostate Cancer: Advanced Stage-Portuguese Version 2020

• Prostate Cancer: Early Stage-Portuguese Version 2020

• Prostate Cancer: Advanced Stage-Russian Version 2020

• Prostate Cancer: Early Stage-Russian Version 2020

• Prostate Cancer: Early Stage-Spanish - Latin America Version 2020

• Prostate Cancer: Advanced Stage-Spanish - Latin America Version 2020

• Prostate Cancer: Early Stage-Ukrainian Version 2020

• Prostate Cancer: Advanced Stage-Ukrainian Version 2020

Educational Events and Programs

Calendar of Events

Continuing Education

• NCCN Guidelines® Insights - Prostate Cancer, Version 1.2023

• NCCN Guidelines® Insights - Prostate Cancer Early Detection, Version 1.2023

• Recognizing Bias and Health Care Disparities in Black Patients

• Prostate Cancer in Black Individuals: How Can We Do Better?

• Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Prostate Cancer

• Management of Metastatic Prostate Cancer

• Clinical Scenario #1: Applying Biomarkers in Risk Stratification of Localized Prostate Cancer

International

Disclosures

• Disclosure Policy

• Panel Member Disclosures

• Panel Member Disclosures by Meeting Date

• End User License Agreement